Edwards Lifesciences Corporation (EW) Revenue Growth
Edwards Lifesciences Corporation (EW) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 15.91% |
| 2018-12-31 | 8.37% |
| 2019-12-31 | 16.79% |
| 2020-12-31 | 0.88% |
| 2021-12-31 | 19.29% |
| 2022-12-31 | 2.86% |
| 2023-12-31 | -6.92% |
| 2024-12-31 | 8.57% |
| 2025-12-31 | 11.55% |
How EW compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| INNV | InnovAge Holding Corp. | 11.76% |
| NEO | NeoGenomics Inc. | 10.11% |
| AMGN | Amgen Inc. | 9.95% |
| VRTX | Vertex Pharmaceuticals Incorporated | 8.90% |
| ABBV | AbbVie Inc. | 8.57% |
These are five companies in the same sector as EW with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Edwards Lifesciences Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("EW", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | EW | $90.74 | -0.01% | 2.54M |
| 3 | ||||
| 4 | ||||
| 5 |